Proceedings of the 2018 5th International Conference on Education, Management, Arts, Economics and Social Science (ICEMAESS 2018)

An Empirical Study on the Impact of drug licensing on sales

Authors
Qi-hang Wang, Chen Cao, Yuan-jia HU
Corresponding Author
Qi-hang Wang
Available Online November 2018.
DOI
https://doi.org/10.2991/icemaess-18.2018.65How to use a DOI?
Keywords
drug licensing, sales, T-test, Q-test
Abstract
To study the impact of drug licensing on its sales, and to provide a reference for drug development and corporation between pharma. METHODS: Based on the variables “license station”, “co-development or co-marketing”, “licensor in accord with key marketing company or not” and “time for drug licensing” which reflected drug licensing and sales, with SPSS statistical software, T-test and Q-test of drug licensing and the sales of drugs were carried out on the 151 sample drugs collected in IMS Health. RESULTS & CONCLUSIONS: Drugs with licensing activities have higher sales than those without licensing. There is no significant difference between co-development and co-marketing for the drugs, Licensor hold the key marketing right helps improve sales of drugs. The optimum time for drug licensing is phase Ⅲ.
Open Access
This is an open access article distributed under the CC BY-NC license.

Download article (PDF)

Cite this article

TY  - CONF
AU  - Qi-hang Wang
AU  - Chen Cao
AU  - Yuan-jia HU
PY  - 2018/11
DA  - 2018/11
TI  - An Empirical Study on the Impact of drug licensing on sales
BT  - Proceedings of the 2018 5th International Conference on Education, Management, Arts, Economics and Social Science (ICEMAESS 2018)
PB  - Atlantis Press
SP  - 312
EP  - 317
SN  - 2352-5398
UR  - https://doi.org/10.2991/icemaess-18.2018.65
DO  - https://doi.org/10.2991/icemaess-18.2018.65
ID  - Wang2018/11
ER  -